INJ Crypto Asset: Founding Team

The Injective Protocol (INJ) was founded in 2017 by a core team with a background rooted in blockchain technology, finance, and software development. Over the years, the team behind Injective has played a critical role in the growth and evolution of decentralized finance (DeFi).

Eric Chen: Co-Founder and CEO

Eric Chen, one of the co-founders and CEO of Injective Labs, has experience working across various sectors of the blockchain industry. Before founding Injective, Chen was involved in cryptographic research and fund management, focusing on innovative decentralized finance solutions. His primary goal with Injective has been to create a platform that facilitates seamless, trustless trading across multiple blockchains. Chen's understanding of both the technical and financial aspects of blockchain technologies has been essential in leading the project toward achieving its objectives.

Albert Chon: Co-Founder and CTO

Albert Chon is the co-founder and Chief Technology Officer of Injective Labs. With a background in computer science and engineering, Chon's role in the development of Injective Protocol focuses on the technological framework that supports its decentralized exchange capabilities. Prior to co-founding Injective, Chon worked at various tech companies and gained experience in building scalable systems. His expertise allows Injective to maintain a robust infrastructure, ensuring that the platform functions smoothly even as it scales. Chon’s development work on Injective has concentrated on seamlessly integrating systems capable of cross-chain compatibility, enabling diverse blockchains to communicate on the platform in an efficient and secure manner.

Backing and Partnerships

The founding team’s vision and technical expertise have attracted high-profile backing and strategic partnerships. One of the most notable instances of external validation came from Binance, a massive player in the cryptocurrency space, through its Binance Labs incubator program. This backing not only provided visibility but also, more importantly, facilitated access to essential resources for continued development. Other key partnerships helped solidify Injective's presence within the DeFi ecosystem, as the team prioritized collaboration within the community.

Team's Technical Focus

One key characteristic of the founding team is their focus on addressing tangible challenges within decentralized finance. They have developed Injective to enable zero gas fees and faster transactions, as well as ensure cross-chain interoperability. The use of an on-chain decentralized order book further distinguishes the platform from many centralized and decentralized exchanges, reflecting the team's commitment to innovation and decentralization.